Gut microbiota and metabolic dysfunction-associated steatotic liver disease (MASLD): emerging pathogenic mechanisms and therapeutic implications

Abdelhameed, F., Mustafa, A., Kite, C. orcid.org/0000-0003-1342-274X et al. (6 more authors) (2025) Gut microbiota and metabolic dysfunction-associated steatotic liver disease (MASLD): emerging pathogenic mechanisms and therapeutic implications. Livers, 5 (1). ISSN 2673-4389

Abstract

Metadata

Item Type: Article
Authors/Creators:
Copyright, Publisher and Additional Information:

© 2025 The Authors. This is an Open Access article distributed under the terms of the Creative Commons Attribution Licence (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Keywords: MASLD; NAFLD; steatosis; liver; gut microbiota; gut microbiome
Dates:
  • Published: 4 March 2025
  • Published (online): 4 March 2025
  • Accepted: 19 February 2025
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Faculty of Medicine, Dentistry and Health (Sheffield) > School of Medicine and Population Health
Depositing User: Symplectic Sheffield
Date Deposited: 14 Mar 2025 11:49
Last Modified: 14 Mar 2025 11:49
Published Version: https://doi.org/10.3390/livers5010011
Status: Published
Publisher: MDPI AG
Refereed: Yes
Identification Number: 10.3390/livers5010011
Open Archives Initiative ID (OAI ID):

Download

Export

Statistics